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Metabolic costs of activities of daily living in
persons with a lower limb amputation: A
systematic review and meta-analysis
Loeke van SchaikID1*, Jan H. B. Geertzen1, Pieter U. Dijkstra1,2, Rienk Dekker1
1 Department of Rehabilitation Medicine, University Medical Center Groningen, University of Groningen, the
Netherlands, 2 Department of Oral and Maxillofacial Surgery, University Medical Center Groningen,




To systematically review the literature on the metabolic costs of activities of daily living
(ADL) in persons with a lower limb amputation (LLA).
Data sources
A literature search was undertaken in the Pubmed, Embase, CINAHL, CENTRAL, and Psy-
cINFO databases using keywords and synonyms for LLA, metabolic costs, and ADL. The
last search was performed on November 29th, 2017.
Study selection
Studies were included if they met the following 2 criteria: participants were adults with a (uni-
lateral or bilateral) LLA and metabolic costs were measured while participants performed a
physical activity or ADL.
Data extraction and synthesis
Data of 1,912 participants from 61 studies were included in the systematic review and meta-
analysis. The studies used different terms to describe metabolic costs. Participants were
recruited in different settings, relatively healthy, with few comorbidities. Limited data were
available on metabolic costs of other activities than walking with a prosthesis. A linear mixed
model analysis was performed based on the means reported, with study as unit of analysis
and test results of different groups and measurement conditions as repeated measures
within the unit of analysis. Predictors entered in the analysis were e.g. level and reason of
amputation, age, weight, and height. During walking, oxygen consumption (ml O2/kg/min)
and heart rate (beats/min) increased with a higher walking speed and a more proximal
amputation. Additionally, oxygen consumption was determined by the interaction terms
walking speed x amputation level and walking speed squared. Heart rate was determined
by the interaction term walking speed squared.
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Conclusion
During walking, oxygen consumption (ml O2/kg/min) and heart rate (beats/min) increased
with a higher walking speed and a more proximal amputation. Data on metabolic costs of
other activities were limited. The poor quality of the studies and the relatively healthy partici-
pants limited generalizability of the results of the meta-analysis.
Introduction
In rehabilitation medicine, the main goals for persons with a lower limb amputation (LLA) are
walking with a prosthesis and regaining functional capacity with regard to activities of daily
living (ADL) [1–3]. To be able to achieve these goals, certain levels of physical and aerobic
capacity are required [4,5].
In the Netherlands, more than 90% of LLAs are due to vascular disease and/or diabetes mel-
litus (DM) [6,7]. In the UK and USA, 75% and 87% of LLAs are due to vascular disease, respec-
tively [8]. Persons with a LLA who have (peripheral) vascular disease (PVD) are mostly elderly
and have comorbidities resulting from atherosclerosis, which limits their physical and aerobic
capacity [9–11]. In general, aerobic capacity decreases with age, and studies have shown that
elderly participants with a LLA have a lower aerobic capacity than controls [12,13]. The
VO2max test is the criterion measure of aerobic capacity, and it is a valid predictor of cardiore-
spiratory capacity [14]. To date, however, few studies have measured VO2max in persons with
a LLA. Furthermore, these studies used different test protocols [10,15,16]. They reported lower
levels of VO2max in participants with a LLA compared with controls. These differences are
probably due to deconditioning or comorbidities.
A previous systematic review looked at the influence of physical capacity on regaining the
ability to walk (with a prosthesis) [17]. No sufficient evidence was found for aerobic and anaer-
obic capacity as potential predictor for walking ability. Another systematic review investigated
factors that predict walking ability after a LLA [18]. One of these factors was fitness of the par-
ticipants. The main finding of this review was the substantial heterogeneity in testing methods
and outcome measures of the included studies, which hampered a meta-analysis. Both system-
atic reviews did not primarily aim to analyse metabolic costs in participants with a LLA, and
both only reviewed walking as activity.
One study reported the relative aerobic load of walking, measured as a percentage of the
VO2peak [19]. The relative aerobic load of walking was higher in participants with a LLA than
in controls. Another study reported that participants with a LLA who had higher levels of
physical fitness (defined as the maximum oxygen uptake during exercise as a proportion of
predicted maximum oxygen uptake) were more likely to walk with a prosthesis than partici-
pants with a LLA with lower levels of physical fitness [10].
For the general population, the metabolic costs of ADL are well reported in the compen-
dium of physical activities, the so called Metabolic Equivalent of Task (MET)-values [20].
However, these reference values seem not to apply for persons with a disability. For example,
in persons after stroke, the required metabolic costs for certain activities are higher compared
to the MET-values [21]. For persons with LLA knowledge about the required metabolic costs
for ADL, in combination with maximum aerobic capacity, is lacking. However, this knowledge
is relevant for optimizing training programs and setting functional goals for rehabilitation.
The specific aims of this systematic review and meta-analysis are 1) to analyse what is
known about the metabolic costs of different ADL in participants with a LLA; 2) to explore
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walking speed; PVD, peripheral vascular disease;
DM, diabetes mellitus.
which methods and outcome measures are used to evaluate these metabolic costs; and 3) to
determine whether metabolic costs are influenced by level of amputation, reason for amputa-
tion, and walking speed.
Methods
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was
used for conducting this systematic review and meta-analysis [22].
Protocol
The protocol for this systematic review and meta-analysis was registrated at PROSPERO
(https://www.crd.york.ac.uk/PROSPERO/#index.php, CRD42016050990).
Study identification and selection
A literature search was performed in the Pubmed, Embase, CINAHL, CENTRAL, and Psy-
cINFO databases. No language or date restrictions were applied. The last search was performed
on November 29th, 2017. Different search terms for LLA were used, combined with various
search terms for metabolic costs and physical activities and/or ADL (S1 File). Two reviewers
(LvS, RD) independently assessed titles and abstracts. In case of disagreement between review-
ers, the record was included for full text analysis. Full text assessment was performed by the
aforementioned reviewers, who used the same criteria for inclusion and exclusion. Any further
disagreements were resolved by consensus through discussion. Cohen’s kappa was calculated
for the title and abstract assessment and the full text assessment of the selection process. The
reference lists of studies included in the systematic review were checked for other relevant
studies, which were subsequently assessed following protocol. When after full text assessment
more than 50 studies resulted, studies with a total study population < 10 were excluded
because the outcomes lacked precision.
Inclusion and exclusion criteria
Inclusion criteria were as follows: participants were adults with a (unilateral or bilateral) LLA
and metabolic costs were measured while participants performed a physical activity or ADL.
Editorials, (expert) opinions, comments, reviews, and off- topic studies were excluded. Studies
on toe or midfoot amputations, amputations other than a lower extremity, or endoprostheses
were also excluded, as were studies with children or animals and model studies.
Quality assessment
Quality assessment was independently performed by two reviewers (LvS, RD) using the
Agency for Healthcare Research and Quality (ARHQ) methodology checklist [23]. Addition-
ally, it was assessed whether equipment for measuring oxygen consumption was validated and
whether walking speed during testing was reported.
Statistical analyses
Statistical analyses were performed using IBM SPSS Statistics 23. Descriptive statistics (mean
and standard deviation) were calculated for study variables. Initially, effect sizes were calcu-
lated based on study data. For oxygen consumption one study, however, reported uncom-
monly small standard deviations relative to other studies, resulting in extremely large effect
sizes [24]. The authors were contacted to verify whether the standard deviations were truly
standard deviations or perhaps standard errors of the mean. The authors did not respond.
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Additionally, 7 studies did not reported standard deviations [25–31]. For heart rate, 5 studies
did not report standard deviations [25,29–32]. Therefore a linear mixed model analysis was
performed (maximum likelihood method and AR1 covariance structure) on the means
reported. The study was used as a unit of analysis and the study results of different groups and
measurement conditions were used as repeated measures within the unit of analysis (multilevel
structure). Forest plots were not made because effect sizes were not used in the analysis.
The outcome oxygen consumption (expressed as ml O2/kg/min) was analysed using the fol-
lowing potential predictors: level of amputation, reason for amputation, age, weight, height,
and walking speed. Only studies that reported oxygen consumption (ml O2/kg/min) were
selected. When possible, outcomes were converted to ml/kg/min. If this was not possible based
on the reported data within the study, the study was excluded for the analysis. Potential predic-
tors were entered into the linear mixed model analysis. If the model fit (-2LL statistic)
increased significantly, the predictors remained in the model. Cause of amputation was catego-
rized in trauma and vascular, level of amputation as below knee and above knee. Studies with
mixed groups (when it was not possible to analyse subgroups based on level and reason of
amputation) were excluded from the analysis.
In a few studies [16,33–35] (n = 4) a treadmill with an incline was used. Data regarding
treadmills with an incline were not included in the meta-analysis because of the small number
of studies. Some studies did not specify whether the walking surface was level. The inclusion
or exclusion of those studies in the meta-analysis did not affect the results. Therefore, studies
that did not specify the treadmill incline were included, and it was assumed the walking surface
was level. Interaction terms of the predictors significantly associated with oxygen consumption
were explored. A similar analysis was performed for heart rate as an outcome measure.
Results
Study inclusion
A total of 2,960 potentially suitable records were found in the database search. After removing
duplicates, 2,537 records remained (Fig 1). After title and abstract assessment, 2,422 records
were excluded (agreement 98%, Cohen’s kappa: 0.71), leaving 115 records for full text assess-
ment. Of 12 records, no full text was available (yet). After full-text analysis, 22 studies were
excluded because they were off topic (agreement was 96%, Cohen’s kappa: 0.88). A further 8
studies were identified from the reference lists and were assessed for inclusion, resulting in a
total of 89 studies. Given the fact that more than 50 studies were identified, studies with a sam-
ple size less of than 10 participants were excluded (n = 27). Two studies were found [36,37]
that partially included the same study population (in one study persons with a Syme amputa-
tion were included and in the other study they were excluded). The former study was included
in this study [36]. In total 61 studies were included. None of the included studies were written
in another language than English or Dutch.
Participant characteristics
The 61 included studies (n = 1,912) were heterogeneous. The mean (SD) number of partici-
pants was 13.5 (13.2). The groups ranged from 10 to 101, and subgroups ranged from 3 to 44.
There were different reasons for amputation and/or levels of amputation. Time since amputa-
tion ranged from 68 days to 27 years (Table 1). The majority of participants were male (68%,
n = 1,299), and for 17% (n = 324) of the participants gender was not specified. The majority of
studies (n = 57) included (subgroups of) participants with a transtibial amputation or a transfe-
moral amputation. A few studies [38–40] included participants with other levels of amputa-
tion. In 12 studies data of participants with different levels of amputation were pooled into a
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single group. The reason for amputation was not described in 8 studies. Eighteen studies
included mixed groups with regard to reason for amputation, and in 8 studies the reason for
amputation was described as ‘other than vascular.’ In 19 studies the use of walking aids was
described (or it was stated explicitly that no aids were used). Comorbidities were reported in 8
studies [10,11,40–45].
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Fig 1. Flowchart showing the inclusion process.
https://doi.org/10.1371/journal.pone.0213256.g001
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Table 1. Participant characteristics of the included studies.




Level amputation (% n) Reason amputation (%) Years since amputation ±SD
(range) �monthsvasc trauma onco other
Ganguli, 1973
[29]
10 (-) 29.9±11 TT (100) - - - - -
C 16 (100) 28.4±7.1 n.a.
James, 1973[33] 37 (100) 42.8±12.8 TF (100) - - - - 18 (2–48)
C 26 (100) 39.6±14.0 n.a.
Ganguli, 1974
[48]
6 (-) 26.2±10.2 TT (100) - - - - 6–12�†
C 6 (100) 34.5±6.2 n.a.
Ganguli, 1975
[30]
10 (100) 27.3±7.1 LLA‡ - - - - -
10 (100) 29.9±1 TT (100) - - - - -
C 16 (100) 28.4±7.1 n.a.
Waters, 1976[4] 13 (-) 60 TF (100) 100 1.2
13 (-) 63 TT (100) 100 1.4
15 (-) 57 Syme (100) 100 1.1
15 (-) 31 TF (100) 100 10.0
14 (-) 29 TT (100) 100 14 (-)
C 50 (-) - n.a.
Huang, 1979[49] 6 (83) 30.4± 8.7 TF (100) - - - - -
6 (50) 38.2±12.9 TT (100) - - - - -
4 (50) 33.5±12.1 TF bil (100) - - - - -
C 25 (20) (19–43) n.a.
Pagliarulo, 1979
[50]
15 (80) 28.9±11.2 TT (100) 100§ > 1†
DuBow, 1983[32] 6 (83) 61±11.3 TT bil (100) 100 1.9±1.1†
C 8 (75) 55±7 n.a.
Nowroozi, 1983
[38]
8 (63) 36.75±17.75 HD (100) 100 -
10 (70) 40±13.2 HP (100) -
C 11 (45) 30.4±10.9 n.a.
Isakov, 1985[11] 14 (93) 60.5
(50–75)
TF (100) 100 1�
3 (100) 35.3
(26–48)
TF (100) 100 > 5
Pinzur, 1992[42] 25 (-) 57.8 TF (20), KD (20), TT (20), Syme (20),
midfoot (20)
100 > 6�†
C 5 (-) 54.5 n.a.
Gailey, 1993[51] 10 (100) 37.2±11.0 TF (100) 100§ 13.6
10 (100) 34.6±9.8 TF (100) 15.4
C 10 (-) 33.2±9.6 n.a.
Jaegers, 1993[52] 11 (100) - TF (100) 100|| -
C 6 (100) - n.a.
Boonstra, 1994
[53]
29 (83) 41±13 TF (100) 3.5 59 34 3.5 19±13
Gailey, 1994[25] 39 (100) 47±16 TT (100) 100§ > 6�
C 21 (100) 31±6 n.a.
Torburn, 1995
[43]
10 (100) 50.6±15.6 TT (100) 100 -
7 (100) 62.0±8.3 100 -
(Continued)
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Table 1. (Continued)




Level amputation (% n) Reason amputation (%) Years since amputation ±SD
(range) �monthsvasc trauma onco other
Hoffman, 1997
[54]
5 (80) 22±3 TF bil (100) 60 40 12.4 (2–24)
C 5 (80) 22±6 n.a.
Chin, 2002[10] 8 (-) 72.2±2.1 TF (100) 100 -
9 (-) 63.2±2.1 TF (100) 100 -
Schmalz, 2002
[55]
7 (100) 49±17 TT (100) 100 23±19
8 (100) 22±17 18±17
6 (100) 33±6 TF (100) 13±6
6 (100) 37±9 13±9
Bussmann, 2004
[56]
10 (90) 64.6±9.6 TF (20), KD (20), TT (60) - - - - 68 days (39–131 days)
C 10 (-) 61.3±11.4 n.a.
Datta,2005[46]¶ 10 (70) 38 (23–46) TF (100) 80 20 �5
Chin, 2006[57] 4 (100) 24.0±7.6 TF (100) 75 25# -
C 14 (71) 25.2±4.0 n.a.
Chin, 2006[39] 34 (71) 67.0±5.6 HD (15),
TF (85)
29 71§ -
15 (67) 67.1±5.7 HD (7),
TF (93)
60 40§ -
Paysant, 2006[24] 10 (100) 39.2 (21–65) TT (100) 100 17.4 (2–38)
C 20 (100) 39.7 n.a.
Hagberg, 2007
[58]
41 (73) 49±11.5 TF (100) 71 24 5 27±14.5
C 22 (73) 49±8.3 n.a.
Seymour, 2007
[59]
13 (85) 46±13 TF (92), KD (8) 100§ 16±15�†
Bussmann, 2008
[60]
9 (100) 55.4 (21–73) TT (100) 100 15.6 (3–61)
C 9 (100) 55.9 (21–76) n.a.
Genin, 2008[61] 10 (100) 34.7±5.1 TF (53) 100 11.2±4.2
9 (100) 35.3±7.3 TT (47)
C 13 (77) 27.8±5.2 n.a.
Kaufman, 2008
[62]
15 (80) 42.9±9 TF (100) 7 47 40 7 20±10
Traballesi, 2008
[44]
16 (69) 61±11 TF (67) 100 -
8 (75) 56±17 TT (33) -
Wright, 2008[63] 10 (100) 40.5±11.9 TT bil (20), TF bil (30), KD bil (10), TT/
TF (40)
80 20 > 22 (2–48)
Hamamura, 2009
[40]
44 (64) 66.7±5.1 HD (23),
TF (77)
27 73§ -





11 (-) 46±9 TT (100) 27 73 >1†
C 11 (-) 47±11 n.a.
Tekin, 2009[34] 10 (100) 27.7±5.3 TT (100) 100 50.3±54.2�
C 9 (100) 28.4±4.2 n.a. 66.1±49.6�
(Continued)
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Table 1. (Continued)




Level amputation (% n) Reason amputation (%) Years since amputation ±SD
(range) �monthsvasc trauma onco other
Goktepe, 2010
[35]
64 (100) 29.1±4.5 TF (15), TT (50), partial foot (35) 100 62.6±50.9�
Andrysek, 2011
[65]
19 (86) 33.4 TF (93), KD (7) 7 57 21 14 13.2
Hagberg, 2011
[66]
28 (71) 49±14.3 HD (7), TF (46), KD (18), TT (29) 61 29 11 18±17†
C 31 (65) 47±10.2 n.a.
Kark, 2011[67] 6 (67) 65±18 TF (100) 17 83 median 22.5 (IQR 40.8)
10 (80) 62±20.8 TT (100) 20 80 median 8.0 (IQR 26.8)
C 28 (43) 59.0±13.0 n.a.
Mohanty, 2012
[68]
30 (87) 34.1±4.4 TT (100) 100 >1�†
Schnall, 2012[26] 12 (100) 26.9±5.5 TT (100) 100 � 6�
C 12 (100) 20.9±2.8 n.a.
Sokhangoei, 2013
[31]
24 (100) 33 (20–40) TT (100) 100 13.7±6.8
C 24 (100) 29.3 n.a.
Wezenberg, 2013
[19]
10 (80) 66.3±5.9 TF (30), TT (70) 100 3.8±3.6
26 (69) 60.7±5.6 TF (38), TT (62) 100 36.2±20.7
C 21 (67) 60.8±5.9 n.a.
Bell, 2014[69] 26 (-) 32±6.1 TF (100) 100 �2
Erjavec, 2014[41] 101 (63) 69.4 (53–84) TF (100) 100 -
Esposito, 2014
[70]
13 (100) 28.9±5.3 TT (100) 100 6.6±6.2�
C 13 (100) 26.5±6.0 n.a.
Gjovaag, 2014
[16]
12 (50) 42.8±13.5 TF (100) 100§ �2
C 12 (50) 43.0±11.7 n.a.
Rowe, 2014[71] 17 (88) 52.2±12.9 TT (100) 59 12 29 8.3±7.6
Vllasolli, 2014
[37]
22 (91) 40.6±12.5 TF (100) 91 9 17.1±10.5
61 (85) 39.7±13.1 TT (100) 95 5 14.5±7.5
6 (83) 36.2±6.2 Syme (100) 100 11.3±2.4
Delussu, 2016[72] 20 (85) 66.6±6.7 TT (100) 65 30 5 0.5†
Esposito, 2016
[73]
6 (83) 29±6 TT (100) 100 2 �†
C 6 (83) 23±5 n.a.
Guirao, 2016[45] 10 (60) 50.3±16.1 TF (100) 40 40 20 8.1
Starholm, 2016
[74]
8 (50) 37.0±10.9 TF (100) 100§ �2
C 8 (50) 39.0±12.3 n.a. 100 27±22�
Andrysek, 2017
[75]
10 (60) 20.9±3.1 TF (100) 40 60 6.8±4.5
Esposito, 2017
[76]
14 (-) 27±5 TF (100) 100 23±11�
C 14 (-) 26±6 n.a.
Gardinier, 2017
[77]
10 (100) 46.5 (20–60) TT (100) - - - - >6�
(Continued)
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One study[46] referred to a previous study for the participant characteristics[47].
Study quality
Agreement for the quality assessment was 93% (Cohen’s kappa: 0.89). The mean quality score
was 6.6, ranging from 3 to 10 points out of 14 possible points (S1 Table). In 43 of the 61 studies
inclusion criteria were reported. Only 22 studies reported exclusion criteria. In 8 studies the
timeframe of recruitment was reported. The majority of studies (n = 56) reported walking
speed(s). Most studies (n = 56) used validated measurement equipment. In a few studies
(n = 5) the type of validation was not explicitly specified.
Study characteristics
All studies had an observational design. Three studies [32,42,68] tested the same measurement
conditions repeatedly. Almost all studies tested walking as an activity, but there was a great
variety in the applied test protocols, test surroundings, and tested walking speeds between
studies (Table 2). Furthermore, different terms for metabolic costs were used, as well as differ-
ent outcome measures. Oxygen consumption (ml O2/kg/min) and heart rate (beats/min) were
Table 1. (Continued)




Level amputation (% n) Reason amputation (%) Years since amputation ±SD
(range) �monthsvasc trauma onco other
C 10 (100) 48.4 (20–63) n.a.
Gjovaag, 2017
[28]
8 (50) 37.0±10.9 TF (100) 100§ 15.9±13.9†
C 8 (50) 39.0±12.3 n.a.
Jarvis, 2017[27] 10 (100) 28±4 TT (100) 100 39±27�
10 (100) 29±3 TF (100) 100 35±7�
10 (100) 29±4 TF bil (100)
C 10 (100) 30±6 n.a.
Lacraz, 2017[78] 15 (75) 46.3±12.7 TT (100) 100 17.6±15.2
Ladlow, 2017[79] 10 (100) 32±5 TT (60), KD (20), TF (20) 100 24±15�
10 (100) 29±4 TT bil (10), KD bil (20), TF bil (30), TT/
TF (20), KD /TF (20)
100 39±14�
C 10 (100) 32±6 n.a.
Mutlu, 2017[80] 13 (-) 44.0±15.9 TF (-), TT(-), Syme (-) - - - - 15.6±14.2†
Weinert, 2017
[81]
8 (-) 38±3 TT (100) 100 �0.5†
9 (-) 28±4 TF (100) 100 �0.5†
10 (-) 29±4 TF bil (100) 100 �0.5†
C 10 (-) 29±4 n.a.
N number participants; C controls;—not reported; vasc vascular; onco oncology; TT transtibial amputation; n.a. not applicable; KD knee disarticulation; TF
transfemoral amputation; bil bilateral; HP hemipelvectomie; HD hipdisarticulation; IQR interquartile range
� months since amputation reported with 1 decimal, no decimal if not reported in the studies
† prosthetic years
‡ not reported in text or table what level of amputation
§ reported as nonvascular
|| trauma or osteosarcoma, no percentages/numbers reported
¶ data reported in other study
# data in text and table differ from each other within the study, data from the table were used
https://doi.org/10.1371/journal.pone.0213256.t001
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Table 2. Study characteristics of the included studies.
Author, year Activity Surrounding Metabolic cost outcome
measures










Indoor Oxygen consumption (l/
min), energy expenditure
† (cal/min/kg), peak HR†
3 - -
James, 1973 Walking level and
5˚ inclination
Treadmill HR, oxygen uptake (l/
min/kg), blood lactate
1.5, 2.7 and 3.9 - TF 95(2), 104(2), 118








Walking Indoor Energy expenditure (kcal/
kg/km and kcal/km), peak
HR‡










Indoor Energy expenditure (kcal/
min) and peak HR
3 - TT 114(-)
Controls 94(-)




- oxygen uptake (ml/kg/
min), net oxygen cost (ml/
kg/m), relative energy cost
(%), HR, RQ
SSWS TF vasc 12.6(2.9),
TT vasc 11.7(1.6), Syme vasc 11.5
(1.5), TF trauma 12.9(3.4), TT
trauma 15.5(2.9)

















Outdoor HR, oxygen consumption,
energy cost (ml/kg/min en
ml/kg/m), RR, BP

















Walking - Oxygen consumption (ml/
min/kg), HR
SSWS, slow and fast HD SSWS 11.1(1.7), SSWS slow
9.3(2.1), SSWS fast 14.5(0.9)
HP SSWS 11.5(3.5), SSWS slow
8.8(3.7), SSWS fast 13.7(4.9)
Controls SSWS 9.8(1.8)















Gailey, 1993 Walking Indoor Oxygen uptake (-), HR 2 and 4 TF CAT CAM 10.4(1.3) and 15.1
(1.9)
TF QUAD 11.7(2.7) and 19.0
(5.5)
Controls 8.5(1.1) and 11.1(1.9)




Controls 84(9) and 90
(9)
Jaegers, 1993 Walking Treadmill Oxygen uptake (l/min),
HR





Walking Treadmill Energy expenditure (J/s/
kg)
2 and 3 -
(Continued)
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Table 2. (Continued)
Author, year Activity Surrounding Metabolic cost outcome
measures












Walking - HR, energy consumption
(ml/kg/min), RQ
SSWS $TT trauma SACH 18.4(3.0),
Carbon Copi II 18.0(3.6), Seatle
light 17.2(3.6), quantum 17.1
(2.7), flex-foot 17.8(3.5)
TT vasc SACH 13.4(2.8), Carbon
Copi II 13.6(1.7), Seatle light 13.7





Walking Indoor Oxygen uptake (l/min),
HR
SSWS, 1.2, 2.2 and 3.3 -# -#
Chin, 2002 Cycling Indoor one
leg cycling
%VO2max n.a. - -
Schmalz,
2002
Walking Treadmill Oxygen rate (ml/min/kg),
HR
Different speeds $TT trauma 1S71 13.5(0.9) and
16.1(1.4), 1D10 13.3(0.8) and
15.5(1.5), 1D25 13.6(0.7) and
15.7(1.2), 1C40 13.5(0.9) and
15.7(1.2), flex foot 13.6(1.2) and
15.6(1.2).
TF trauma SSWS 3C1 15.1(1.1),
C-leg 14.2(1.2). SSWS slow 3C1
12.9(0.9), C-leg 12.1(1.1), SSWS










Datta,2005 Walking Treadmill Oxygen cost (ml/kg/m) Start 2.5, 0.5 increments
at 3min interval, up to 5
-# -
Chin, 2006 Walking - Oxygen uptake (ml/kg/
min) Oxygen cost (ml/kg/
m)
1.8, 3.0, 4.2 and 5.4 TF C-leg 11.6(2.6), 15.6(4.3), 20.1
(3.6), 26.9(5.2)
TF IP 12.4(5.7), 16.3(4). 21(4.3),
28.1(5.4)
Controls 8.7(1.9), 10.4(2.5), 13.3
(3.1), 17.3(3.2)
-






Outdoor Oxygen uptake (ml/kg/
min), oxygen cost (ml/kg/
m), HR
- TT gras flat 15.1(0.2), grass
uneven 18.3(0.2), asphalt 14.6
(0.2).
Controls grass flat 14.1(0.2),
grass uneven 15.7(0.1), asphalt
13.4(0.2)













Walking Treadmill HR, oxygen consumption
(ml/kg/min), oxygen cost
(ml/kg/m)
SSWS and fast SSWS TF/KD SSWS C-leg 12.6(1),
NMC 13.5(2)














Genin, 2008 Walking Outdoor Gross cost (J/kg/m), net
cost (J/kg/m)
1.1 to 8.3 - -
(Continued)
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Table 2. (Continued)
Author, year Activity Surrounding Metabolic cost outcome
measures






Walking Treadmill Objective measurements
of energy efficiency (ml/
kg/m)





HR, energy cost (ml/kg/
m)
SSWS TT treadmill 12.3(2.5), floor 13.5
(2.4)










One leg cycling test Indoor %VO2max n.a. - -
Houdijk,
2009
Walking Treadmill Metabolic energy
consumption (J/kg/s) and
metabolic energy cost (J/
kg/m)
SSWS and 4.7 - -
Tekin, 2009 Walking Treadmill EEI (ml/kg/min) 1.5 and 3, 0˚ en 5˚
inclination
TT trauma 7.5(1.3), 9.5(2.1),
5˚ inclination 8.3(1.8) and 10.3
(2.4).
Controls (salvage) 7.6(1.20), 9.5
(2.1),




Walking Treadmill oxygen consumption (ml/
kg/min), oxygen cost (ml/
kg/m)
1.5 and 3, 0˚ en 5˚
inclination
TT 7.1(1.7), 9.3(2.4), 5˚
inclination 7.6(1.8) and 10.9(2.4).










HR, PCI SSWS - 106(15), 108(17)
Controls 96(12), 97
(12)











Indoor Oxygen uptake (ml/min),
HR, energy expenditure
(kcal/min)




Schnall, 2012 Walking and with
32.7kg load
Treadmill Oxygen consumption (ml/
kg/min)


















SSWS ± 15% en 30%





Bell, 2014 Walking - HR, oxygen cost (ml/kg/
min)
SSWS 4 and 4.6 17.3(5),
17.3(2.7)
127(18), 124(23)
Erjavec, 2014 Walking and hand
wheel ergometer
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Table 2. (Continued)
Author, year Activity Surrounding Metabolic cost outcome
measures










TT 9.5(1.1), 10.9(0.9), 12.7(1.1),
15.5(1.6), 19.1(2.3).
Controls 9.6(1.0), 10.9(1), 12.8
















in the 3rd min, until
exhaustion,
jogging 7–8, inclination
1% every 60 sec till 5,2%,
increased speed with 1

















Walking - HR, PCI SSWS - -
Delussu,
2016












Enforced 4.5 TT ESR 13.4(0.9), BiOM 11.3
(0.9), controls 12.2(1.2)
5˚ inclination ESR 23.1(2.5),
BiOM 21.6(0.9), controls 20.9
(2.2)
-









SSWS TF indoor 12.4(1.5), 15.8(3.4),
treadmill 12.4(2.1), 15.6(2.8)
Controls indoor 13.2(4), 14.6










Oxygen rate (ml O2/kg/




TT 13.7(2.4), 15.8(2), 18.7(2.1),
22.7(2) SSWS indoor 19.2(3.2)
Controls 9.6(1), 10.9(0.9), 12.7











Walking Indoor Oxygen consumption (ml/
kg/min), cost of transport
(J/N�m)









cost of walking (ml/kg/m)
SWSS, speeds 12.5% and





Jarvis, 2017 Walking Indoor Oxygen cost (ml/kg/m),
oxygen consumption (ml/
kg/min)
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the most frequently reported outcome measures of metabolic costs in 39 and 36 studies,
respectively (Table 2, S2 Table). Therefore, these 2 outcome measures were used in the meta-
analysis.
Meta-analysis
The heterogeneity of the study populations, test protocols and the inconsistent reporting influ-
enced the possibilities for statistical analysis.
When study was used as the unit of analysis, for oxygen consumption 23 studies were
included in the mixed model analysis. The following significant predictors for oxygen con-
sumption (ml O2/kg/min) were found: level of amputation, walking speed, and the interaction
terms walking speed squared and walking speed x amputation level (Fig 2, Table 3). When
adding reason of amputation to the model, 4 studies were excluded because of missing data,
the model fit did not improve and the coefficients were not significant. Similar findings
occurred when walking over ground vs. treadmill walking was added to the model.
For heart rate, 20 studies were included in the mixed model analysis. Significant predictors
for heart rate were amputation level, walking speed, and walking speed squared. No other
interaction terms or other factors (e.g. reason of amputation and treadmill vs. over ground)
were found to be significant (Fig 3, Table 4).
Discussion
Sixty-one studies (reporting on 1,912 participants) were included in this systematic review and
meta-analysis. A linear mixed model was used to analyse the data. It was found that reported
mean oxygen consumption (ml O2/kg/min) was influenced by amputation level, walking
speed, and the interaction terms walking speed squared and walking speed x amputation level.
Multiple previous studies reported that higher metabolic costs are associated with a more
proximal level of amputation [4,5,13,82]. Previous studies also found that participants with a
Table 2. (Continued)
Author, year Activity Surrounding Metabolic cost outcome
measures




Ladlow, 2017 Walking Treadmill MET, RPE Enforced and with 3˚
and 5˚ inclination
- -
Mutlu, 2017 Walking, stair
ascending/
descending
Indoor 6MWT, BP, HR SSWS, 10 stairs up &
down tests with/without
250g extra load




Walking Indoor Oxygen consumption (-) SSWS - -
n.a. not applicable;—not reported; SSWS self-selected walking speed; TT transtibial amputation, TF transfemoral amputation, KD knee disarticulation, bil bilateral; HR
heart rate; BP blood pressure; PSPC pneumatic swing-phase control; NMC non-microprocessor control knee, ESR energy storing and return, BiOM bionic powered
ankle–foot prosthesis 6MWT 6-min walking test; RQ respiratory quotient; RR respiratory rate (breaths/min); PCI physiological cost index ((mean HR(work)-mean HR
(rest))/gait speed); %PMHR % predicted max heart rate; %HRR % heart rate reserve; EEI energy expenditure index; RER respiratory exchange ratio; MET Metabolic
Equivalent of Task
� all walking speeds are converted to km/h
† result only in figures
‡ no outcome measure/numbers published
$ 5 different prosthetic feet
#results displayed only in figures, no numbers
https://doi.org/10.1371/journal.pone.0213256.t002
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LLA adapt their self-selected walking speed (SSWS) in order to compensate for the higher met-
abolic costs [4,19,43,58]. The extent to which the SSWS is reduced depends on level of amputa-
tion [4,19,58]. The effect of walking speed on metabolic costs is also found in our analysis (Fig
2). In the multilevel analysis an increase in oxygen consumption was found at higher walking














































Walking speed (m/min) 
Control Transtibial Transfemoral Control Transtibial Transfemoral
Fig 2. Oxygen consumption, regression lines, and the reported means for oxygen consumption (mL O2/kg/min) of the included studies.
https://doi.org/10.1371/journal.pone.0213256.g002
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with a transfemoral amputation. However, there was no significant difference between
reported means for controls and participants with a transtibial amputation. This lack of differ-
ence can be due to the included studies. For example, one study [70] measured the oxygen
consumption in participants with a traumatic transtibial amputation and controls at walking
speeds up to>100 m/min (Fig 2). Compared with the controls, the oxygen consumption of
Table 3. Estimated mean oxygen consumption (ml O2/kg/min) based on the meta-analysis.
Predictor Beta Std. Error P value 95% Confidence Interval
Lower Bound Upper Bound
Intercept 7.2 1.4 <0.001 4.3 10.0
Transfemoral 2.2 1.0 0.025 0.3 4.1
Transtibial 2.4 1.1 0.036 0.2 4.6
Walking speed (m/min) -3.6 �10−3 3.8�10−2 0.925 -7.9�10−2 7.2�10−2
Walking speed2 (m/min) 1.1�10−3 3.1�10−4 0.001 4.8�10−4 1.7�10−3
Transfemoral � walking speed2 5.5�10−4 1.8�10−4 0.002 2.0�10−4 0.9�10−3
Transtibial � walking speed2 -1.9�10−4 1.9�10−4 0.306 -5.7�10−4 1.8�10−4
Included studies [4,16,17,22,23,25,26,32,33,41,42,46,47,51,54,56,66,67,69–71,73,74].
https://doi.org/10.1371/journal.pone.0213256.t003
Fig 3. Heart rate, regression lines, and the reported means for heart rate (beats/min) of the included studies.
https://doi.org/10.1371/journal.pone.0213256.g003
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the participants at the highest walking speed was not significantly different (19.1±2.3 ml O2/
kg/min vs. 18.9±1.8 ml O2/kg/min). In the multilevel analysis an interaction effect between
walking speed squared and group was found, indicating that the effect of walking speed
squared was not the same for groups. This interaction effect can be related to amputation level,
but also to differences between studies including differences in methodology i.e. measurement
procedures, general health, body weight, height, physical condition, and or age of the partici-
pants. However source studies report too inconsistently to be able to include these confound-
ers in the regression analyses. The curve is based on the regression coefficients of the linear
mixed model analysis of the reported means in the studies. Different study designs and hetero-
geneity in study populations may influence the reported means and therefore the regression
curve.
One of the most noteworthy findings was that reason of amputation was not a predictor in
the multilevel analysis, which may be related to the limited number of studies analysing partic-
ipants with a vascular amputation. Additionally, many studies did not report on reason of
amputation, had a mixed group of reasons of amputation, without specifying outcomes for
separate groups. When adding reason of amputation to the mixed model analysis, 4 studies
were excluded and coefficients were not significant. However, some previous studies report
higher metabolic costs for walking in participants with a dysvascular amputation [4,19]. One
study reported that the metabolic costs (measured by oxygen consumption (mL O2/kg/min))
of walking in participants with a traumatic LLA at SSWS were equal to those of controls,
whereas the SSWS of the LLA group was slower than that of the control group [19]. In the
group of participants with a dysvascular LLA, SSWS was slower. Even when participants with
a dysvascular LLA adapted their SSWS, the metabolic costs were higher [63]. However, this
study included mixed groups for level of amputation. When walking faster than their SSWS, 2
studies found higher oxygen consumption for participants with a traumatic LLA compared to
controls [19,58].
The other frequently used outcome measure of metabolic costs was heart rate (beats/min).
Studies reported heart rate were not all the same studies included in the analysis for oxygen
consumption. Therefore, a different study population is analysed (Table 2), with a total of 20
included studies. The majority of studies using this specific outcome measure did not include
participants with a LLA due to PVD. Generally, measuring heart rate is more accessible com-
pared to oxygen consumption or VO2max, because in most of the settings equipment for mea-
suring oxygen consumption and/or VO2max is not available. Furthermore, it is questionable
whether heart rate is a good predictor of metabolic costs in persons with an amputation due to
vascular disease and/or DM, because they often have comorbidities such as cardiovascular dis-
ease and are likely to use medication that influences their heart rate. Significant predictors of
heart rate as an outcome measure were walking speed, amputation level, and walking speed
squared. Reason for amputation was not a significant predictor of heart rate.
Table 4. Estimates mean heart rate (beats/min) based on meta-analysis.
Predictor Beta Std. Error P Value 95% Confidence Interval
Lower Bound Upper Bound
Intercept 74.5 4.8 <0.001 64.9 84.0
Transfemoral 26.1 2.2 <0.001 21.6 30.5
Transtibial 17.6 2.1 <0.001 13.4 21.8
Walking speed (m/min) 5.7�10−2 1.5�10−1 0.703 -0.2 0.3
Walking speed2 (m/min) 2.8�10−3 1.2�10−3 0.028 3.0�10−4 5.2�10−3
Included studies: [4,23,28–31,39,42,44,46,47,55,56,63,65,67–69,73,77].
https://doi.org/10.1371/journal.pone.0213256.t004
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As stated previously, the VO2max-test is seen as the criterion measure of physical and aero-
bic capacity. Only a few studies [10,16,62,69] measured (%)VO2max in participants with a
LLA. Only one study reported the relative aerobic load of walking, measured as a percentage of
the VO2peak [19]. For walking, the relative aerobic load was found to be higher in participants
with a LLA than in controls. Another study reported that participants with a LLA who had
higher levels of physical fitness (defined as the maximum oxygen uptake during exercise as a
proportion of predicted maximum oxygen uptake) were more likely to walk with a prosthesis
than participants with a LLA with lower levels of physical fitness [10]. Therefore, VO2max may
be used as an indicator for walking ability and for (physical) training in persons with a LLA.
Additionally, it is relevant to know an individual’s aerobic capacity in combination with the
metabolic costs of daily activities, to be able to evaluate the individual strain of ADL. Possible
explanations for the lack of VO2max-testing in persons with a LLA are comorbidities, lack of
knowledge of this type of testing, lack of knowledge of the interpretation of the test results,
costs, and lack of facilities.
Previous systematic reviews did not primarily aim to analyse metabolic costs of ADL in par-
ticipants with a LLA [17,18]. They found no sufficient evidence for a relation between other
measures of physical capacity, such as aerobic and anaerobic capacity, and walking ability. The
main finding was the heterogeneity in measurement methods and outcome measures. This
finding is in keeping with the results from our study. Studies included in our systematic review
and meta-analysis were also heterogeneous with respect to number of participants, participant
characteristics, study characteristics, statistical analyses, test protocols, and outcome measures.
The heterogeneity and the poor reporting influenced our statistical analysis. It was not possible
to make forest plots or use effect sizes in the meta-analysis, therefore a conventional meta-anal-
ysis was not possible. A linear mixed model analysis was performed on the means reported,
with study as unit of analysis and study results of different groups and measurement condi-
tions as repeated measures within the unit of analysis. Despite the shortcomings of the source
studies we were able to identify 2 factors (amputation level and walking speed) influencing
oxygen consumption and heart rate. By combining several studies a more precise estimate was
found than in single studies. All studies were of observational design, were blinding partici-
pants or investigators was not possible. In 43 of the 61 studies inclusion criteria were reported,
and in only 22 studies reported exclusion criteria (S1 Table), therefore it is not clear if there
was a selection bias. The majority of the included studies did report the tested walking speeds
and used validated equipment. Because of the limited reporting, it was not possible to analyse
predictors such as age, height, and type of prosthesis (prosthetic knee/foot), because too few
studies reported sufficient details. When the aforementioned predictors were added to the sta-
tistical model, the number of studies available for analysis decreased considerably, thereby pre-
venting further analysis. Consequently, no conclusions could be drawn from these predictors.
Of the included 61 studies, 3 studies reported on metabolic costs for walking stairs
[29,30,80]. One of these studies compared heart rate for walking stairs with and without extra
weight in participants with LLA and found that in both situations heart rate increased [80].
The other 2 studies measured metabolic costs (kcal/min) and heart rate [29,30]. They found a
significant difference for metabolic costs (kcal/min), but no significant difference in heart rate
for ascending stairs compared to controls. One other study measured different walking condi-
tions outdoors (asphalt, mown lawn and high grass) in high functioning participants with trau-
matic transtibial amputation [24]. They report significant increase in oxygen consumption (ml
O2/kg/min) and heart rate for walking in high grass, no significant differences for the other 2
conditions were found. As previously mentioned, the rehabilitation of persons with a LLA is
not only aimed at walking with prosthesis, but also at regaining functional capacity and
Metabolic costs of activities of daily living in persons with a lower limb amputation
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independency with regard to ADL. However, limited data are available on metabolic costs of
other activities than walking with a prosthesis.
Study limitations
The results of this systematic review and meta-analysis were dependent on the quality of
research of the available studies. The included studies reported poorly on details of the study
populations and potential predictors of metabolic costs in participants with a LLA. Because of
the heterogeneity and the limited reporting, the mixed model analysis was performed with
reported means, with study as unit of analysis. Furthermore, the studies included relatively
healthy participants and, as mentioned before, data on metabolic costs for other ADL than
walking is very limited.
Future research
Further research on the metabolic costs of walking, and daily activities in persons with a LLA
is relevant in order to gather data that will help with setting functional goals, optimizing indi-
vidual training, and evaluating LLA-rehabilitation. Study populations and subgroups should
be described with sufficient detail regarding reason for amputation, age, gender, and level of
amputation to improve generalizability. The inclusion of participants with different levels of
amputation in a mixed group should be avoided.
From a clinical perspective, it is important to assess the metabolic costs of ADL and the
physical capacity of persons with a LLA in order to optimize their rehabilitation program,
train them at an optimal walking speed, improve their potential to walk with a prosthesis, and
help them regain functional capacity with regard to ADL.
Conclusion
In general oxygen consumption and heart rate for persons with transtibial and transfemoral
amputation while walking are higher than for controls. A higher walking speed is associated
with a higher oxygen consumption and this increase was stronger for persons with a transfe-
moral amputation compared to controls. Source studies report inconsistently, therefore it is
not possible to include other possible confounders in the analyses such as age and cause of
amputation.
Limited information is available on metabolic costs of other activities than walking. The
quality of the included studies was low; therefore, the results of this systematic review should
be regarded with some caution.
Supporting information
S1 Table. AHRQ Cross-Sectional/Prevalence study quality assessment checklist. Y yes, N
no, N.A. not applicable, ? not specified/unknown. �1. Was the source of information for the
reported outcome measurements mentioned? 2.Were inclusion criteria reported? 3. Were
exclusion criteria reported? 4. Was the timeframe of recruitment reported? 5. Were subjects
consecutively recruited or population-based? 6. Were evaluators of subjective components
masked to other aspects of the subjects? 7. Have any assessments been undertaken for quality
assurance purposes (test/retest of primary outcome measurements)? 8. Was the used equip-
ment validated or were there references to validation in previous publications? 9. Were all par-
ticipants included in the analysis? 10.Was confounding assessed and/or controlled for? 11.
Were missing data reported? 12. Were patient response rate and completeness of data collec-
tion reported? 13. Were follow-up, incomplete data, or loss to follow-up reported? 14. Was
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tested walking speed reported?
(DOCX)
S2 Table. Frequencies of the reported outcome variables. HR heart rate; PCI physiological
cost index; %HRR % heart rate reserve; RER respiratory exchange ratio; RR respiratory rate;
BP blood pressure; METs metabolic equivalent of task; RQ respiratory quotient; EEI energy
expenditure index.
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S1 File. Details of the full search strategy.
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